Finance

Monogram Biosciences announces Q2 2006 revenue of $13.4 million, up 8% from Q2 2005

Published in AIDS Weekly, August 21st, 2006

Monogram Biosciences, Inc. (MGRM), in its financial results for the quarter ended June 30, 2006, reported revenue of $13.4 million for the second quarter of 2006, which was 8% higher than revenue of $12.4 million for the second quarter of 2005.

Driving this increase was revenue from the company's HIV testing products, which grew 16% to $12.8 million in the second quarter of 2006 compared to $11 million for the same period in 2005.

For the second quarter of 2006, a net loss of $21.8 million, or 17 cents per common share, was recorded, compared to a net profit of $700,000, or 1 cent per common share, for the same period in 2005. Included in these...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2006-08-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry